제 2형 당뇨병에서 발생한 막증식성 사구체신염 1예
A Case of Membranoproliferative Glomerulonephritis in a Patient with Type 2 Diabetes Mellitus
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Diabetic nephropathy (DN) is a common complication and the leading cause of end-stage renal disease (ESRD) in diabetic patients. The occurrence of non-diabetic renal disease (NDRD) in diabetic patients has been increasingly recognized in recent years. Generally, renal injuries in DN are deemed difficult to reverse, whereas some NDRDs are often treatable and even remittable. Thus, the diagnosis of NDRD in patients with diabetes mellitus (DM) via a kidney biopsy would be significant for its prognosis and therapeutic strategy. According to recent studies, the most common NDRD is IgA nephropathy in type 2 diabetic patients, and some cases of minimal change disease and membranous glomerulonephritis have been reported in Korea. However, membranoproliferative glomerulonephritis (MPGN) is an uncommon condition in diabetic patients. To our knowledge, there has been no case yet of MPGN, except in a child with type 1 DM. We present an unusual case of a 27-year-old woman who had type 2 DM with MPGN, as confirmed via a kidney biopsy.
Abstract
Diabetic nephropathy (DN) is a common complication and the leading cause of end-stage renal disease (ESRD) in diabetic patients. The occurrence of non-diabetic renal disease (NDRD) in diabetic patients has been increasingly recognized in recent years. Generally, renal injuries in DN are deemed difficult to reverse, whereas some NDRDs are often treatable and even remittable. Thus, the diagnosis of NDRD in patients with diabetes mellitus (DM) via a kidney biopsy would be significant for its prognosis and therapeutic strategy. According to recent studies, the most common NDRD is IgA nephropathy in type 2 diabetic patients, and some cases of minimal change disease and membranous glomerulonephritis have been reported in Korea. However, membranoproliferative glomerulonephritis (MPGN) is an uncommon condition in diabetic patients. To our knowledge, there has been no case yet of MPGN, except in a child with type 1 DM. We present an unusual case of a 27-year-old woman who had type 2 DM with MPGN, as confirmed via a kidney biopsy.
참고문헌 (24)
- 진동찬, "Current Status of Dialysis Therapy in Korea", The Korean Journal of Internal Medicine, 26(2), pp.123~131 (2011), 대한내과학회
- Pham TT, "Prevalence of nondiabetic renal disease in diabetic patients", Am J Nephrol, 27, pp.322~328 (2007)
- 김병수, "제2형 당뇨병 환자에서 당뇨병성 신증과 비당뇨병성 신질환의 임상적 차이", Kidney Research and Clinical Practice, 28(6), pp.588~594 (2009), 대한신장학회
- Suzuki D, "Evaluation of renal biopsy samples of patients with diabetic nephropathy", Intern Med, 40, pp.1077~1084 (2001)
- Sethi S, "Membranoproliferative glomerulonephritis secondary to monoclonal gammopathy", Clin J Am Soc Nephrol, 5, pp.770~782 (2010)
- Sethi S, "Membranoproliferative glomerulonephritis--a new look at an old entity", N Engl J Med, 366, pp.1119~1131
- Jung YC, "Clinical and pathological characteristics of membranoproliferative glomerulonephritis in Korean adults", Korean J Nephrol, 17, pp.53~65 (1998)
- Alchi B, "Membranoproliferative glomerulonephritis", Pediatr Nephrol, 25, pp.1409~1418 (2010)
- Rennke HG, "Secondary membranoproliferative glomerulonephritis", Kidney Int, 47, pp.643~656 (1995)
- Varade WS, "Patterns of complement activation in idiopathic membranoproliferative glomerulonephritis, types I, II, and III", Am J Kidney Dis, 16, pp.196~206 (1990)
- Ruley EJ, "Hypocomplementemia of membranoproliferative nephritis. dependence of the nephritic factor reaction on properdin factor B", J Clin Invest, 52, pp.896~904 (1973)
- Jennette JC, "Heptinstall’s pathology of the kidney" (2007), Lippincott Williams &Wilkins
- Somers M, "Non-nephrotic children with membranoproliferative glomerulonephritis: are steroids indicated?", Pediatr Nephrol, 9, pp.140~144 (1995)
- Little MA, "Severity of primary MPGN, rather than MPGN type, determines renal survival and post-transplantation recurrence risk", Kidney Int, 69, pp.504~511 (2006)
- Cameron JS, "Idiopathic mesangiocapillary glomerulonephritis. comparison of types I and II in children and adults and long-term prognosis", Am J Med, 74, pp.175~192 (1983)
- Neugarten J, "Glomerulonephritis in bacterial endocarditis", Am J Med, 77, pp.297~304 (1984)
- Alric L, "Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN", Am J Kidney Dis, 43, pp.617~623 (2004)
- Bartel C, "Remission of a B cell CLL-associated membranoproliferative glomerulonephritis Type I with rituximab and bendamustine", Clin Nephrol, 69, pp.285~289 (2008)
- McEnery PT, "The effect of prednisone in a high-dose, alternate-day regimen on the natural history of idiopathic membranoproliferative glomerulonephritis", Medicine (Baltimore), 64, pp.401~424 (1985)
- Cattran DC, "Results of a controlled drug trial in membranoproliferative glomerulonephritis", Kidney Int, 27, pp.436~441 (1985)
- Levin A, "Management of membranoproliferative glomerulonephritis:evidence-based recommendations", Kidney Int Suppl, 70, pp.S41~S46 (1999)
- Mak SK, "Clinical predictors of non-diabetic renal disease in patients with non-insulin dependent diabetes mellitus", Nephrol Dial Transplant, 12, pp.2588~2591 (1997)
- Yaqub S, "Non-diabetic renal disease in patients with type-2 diabetes mellitus", Saudi J Kidney Dis Transpl, 23, pp.1000~1007 (2012)
- Schmitt H, "Long-term prognosis of membranoproliferative glomerulonephritis type I. Significance of clinical and morphological parameters: an investigation of 220 cases", Nephron, 55, pp.242~250 (1990)